{"id":"NCT00956254","sponsor":"INSYS Therapeutics Inc","briefTitle":"Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral Mucositis","officialTitle":"Evaluate Safety and Tolerability and Compare Absorption/Distribution Kinetics of a Single 100 Mcg Dose of Fentanyl Sublingual Spray (Fentanyl SL Spray) in Cancer Subjects With or Without Oral Mucositis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-10","primaryCompletion":"2010-10","completion":"2010-10","firstPosted":"2009-08-11","resultsPosted":"2013-09-05","lastUpdate":"2013-09-05"},"enrollment":18,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Mucositis","Pain","Unspecified Adult Solid Tumor, Protocol Specific"],"interventions":[{"type":"DRUG","name":"Fentanyl sublingual spray","otherNames":[]}],"arms":[{"label":"Fentanyl sublingual spray 100 µg","type":"EXPERIMENTAL"}],"summary":"This was an open-label, single-dose study to assess the safety, tolerability, and absorption/distribution kinetics of a single 100 µg dose of fentanyl sublingual spray in opioid-tolerant cancer subjects, with or without oral mucositis.","primaryOutcome":{"measure":"Cmax of Fentanyl","timeFrame":"Pre-dose to 12 hours post-dose","effectByArm":[{"arm":"Fentanyl Sublingual Spray 100 µg - Mucositis","deltaMin":0.67,"sd":0.6},{"arm":"Fentanyl Sublingual Spray 100 µg - Non-mucositis","deltaMin":0.26,"sd":0.15}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":9},"commonTop":["Burning sensation mucosal"]}}